vatalanib has been researched along with alpha-aminopyridine in 1 studies
Studies (vatalanib) | Trials (vatalanib) | Recent Studies (post-2010) (vatalanib) | Studies (alpha-aminopyridine) | Trials (alpha-aminopyridine) | Recent Studies (post-2010) (alpha-aminopyridine) |
---|---|---|---|---|---|
276 | 42 | 98 | 5,813 | 460 | 3,246 |
Protein | Taxonomy | vatalanib (IC50) | alpha-aminopyridine (IC50) |
---|---|---|---|
Botulinum neurotoxin type A | Clostridium botulinum | 1.8 | |
Nitric oxide synthase, endothelial | Homo sapiens (human) | 2.8 | |
Nitric oxide synthase, brain | Homo sapiens (human) | 6 | |
Nitric oxide synthase, brain | Rattus norvegicus (Norway rat) | 9 | |
Nitric oxide synthase, inducible | Homo sapiens (human) | 1.9 | |
Phosphatidylinositol 4-kinase alpha | Homo sapiens (human) | 7.1 | |
Phosphatidylinositol 4-kinase type 2-beta | Homo sapiens (human) | 7.1 | |
Phosphatidylinositol 4-kinase type 2-alpha | Homo sapiens (human) | 7.1 | |
Phosphatidylinositol 4-kinase beta | Homo sapiens (human) | 7.1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Aarts, MJB; Eble, JA; Fernandez, DI; Heemskerk, JWM; Kuijpers, MJE; Tullemans, BME; van der Meijden, PEJ; Veninga, A | 1 |
1 other study(ies) available for vatalanib and alpha-aminopyridine
Article | Year |
---|---|
Multiparameter Evaluation of the Platelet-Inhibitory Effects of Tyrosine Kinase Inhibitors Used for Cancer Treatment.
Topics: Aminopyridines; Antineoplastic Agents; Blood Platelets; Calcium Signaling; Collagen; Dasatinib; Dose-Response Relationship, Drug; Drug Repositioning; Humans; Morpholines; Phthalazines; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Thrombosis | 2021 |